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ABSTRACT 
 Chlamydia trachomatis is the most prevalent agent of bacterial sexually 
transmitted infections in the world. However, a profuse number of cases are 
unreported, as the infection is often asymptomatic. Sequelae such as pelvic 
inflammatory disease, an increased risk of cervical cancer, premature birth, and 
perinatal infections in pregnant women can occur. Inflammation occurs in the 
body in response to infection or injury. Although inflammation can lead to some 
unwanted secondary effects, such as pain, it serves to return the body to 
homeostasis by restoring injured tissues and eliminating pathogens. One recently 
identified connection between the central nervous system and the immune 
system that regulates inflammation is the cholinergic anti-inflammatory pathway 
(CAP). In the CAP, pathogen-associated molecular patterns stimulate the vagus 
nerve to activate the pathway, which ultimately results in acetylcholine (ACh) 
release, which down regulates inflammation. We hypothesized that genital 
chlamydial infection would increase the expression of choline acetyltransferase 
(ChAT), the enzyme that synthesizes ACh, in the female murine genital tract, 
therefore down regulating inflammation and promoting chlamydial infection. 
Transgenic female mice carrying a ChAT-promoter driven GFP reporter gene 
were vaginally infected with C. muridarum. Mice were sacrificed on days 3, 9, 15, 
and 21 post infection; cervical, uterine horn, and ovarian tissues were removed 
and embedded in paraffin. Small sections of each tissue were cut and mounted 
onto slides. The tissue sections were then stained for the expression of ChAT 
using immunohistochemical techniques. Finally, tissue sections were viewed 
under a microscope for positive staining and the data was analyzed. The results 
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indicated that there is a significant increase in the number of cells that express 
ChAT in genital tract of chlamydia-infected mice versus non-infected mice.  
INTRODUCTION 
Chlamydia trachomatis is the most prevalent agent of bacterial sexually 
transmitted infections in the world. One hundred one million infections are 
caused by this bacterium each year, as reported by the World Health 
Organization (Malhotra et al., 2013). However, a substantial number of cases are 
unreported, as the infection is asymptomatic in 10% of men and 5-30% of 
women. A sexually transmitted infection of Chlamydia trachomatis can manifest 
as cervicitis, urethritis, and, or, proctitis (CDC, 2016). Sexually transmitted 
infections caused by this agent are more common in women; sequelae such as 
pelvic inflammatory disease, an increased risk of cervical cancer, premature 
birth, and perinatal infections in pregnant women can occur. In fact, in the United 
States about 20%-30% of cases of pelvic inflammatory disease are accounted for 
by Chlamydia trachomatis. Reinfections or chronic infections with C. trachomatis 
can occur, in which delayed hypersensitivity reactions can develop. The immune 
response that ensues in these chronic infections can cause damage such as the 
formation of scar tissue and fibrosis in the genital tract – which can lead to 
infertility or life-threatening ectopic pregnancy (Malhotra et al., 2013). C. 
trachomatis can also be transmitted from mother to child in the birth canal, which 
can result in pneumonia and, or conjunctivitis in the neonate (Hogan et al., 2004).  
 C. trachomatis is a obligate intracellular Gram-negative pathogen with a 
biphasic developmental cycle (Figure 1). First, elementary bodies enter host 
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genital epithelial cells. Elementary bodies are infectious, but are less 
metabolically active and unable to reproduce. Once inside the cell, within a 
membrane bound vesicle called an inclusion, elementary bodies differentiate into 
reticulate bodies. Reticulate bodies are more metabolically active than EB and 
divide inside of the inclusion, but are unable to infect other cells. An unknown cue 
causes the reticulate bodies to differentiate back into elementary bodies. These 
progeny elementary bodies are released from the cell by either host cell rupture 
or inclusion extrusion and can go on to infect other cells and repeat this 
developmental cycle (Wolf et al., 2006).  
 
 
Figure 1. Chlamydial Developmental Cycle 
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Cholinergic neurotransmission is one of the central means by which the 
body maintains homeostasis, and therefore life (Wessler and Kirkpatrick, 2008). 
In animals, acetylcholine (ACh) is synthesized by the enzyme choline 
acetyltransferase (ChAT) (Wessler et al., 1998). Cholinergic neurons release 
ACh into the synaptic cleft; these neurotransmitters act on nicotinic and 
muscarinic receptors to carry out neurotransmission. Not only is ACh an 
important neurotransmitter, but it also has other important signaling functions. 
Even in organisms like bacteria, fungi, algae, and protozoa, that do not have 
neurons, cholinergic communication has been found (Wessler and Kirkpatrick, 
2008). Thus, it is not surprising that the ChAT enzyme, ACh, and nicotinic and 
muscarinic receptors for ACh have also been found in non-neuronal cells in 
mammals. Many non-neuronal cells produce ACh, and most of these cell types 
also express nicotinic and muscarinic receptors that play a role in the autocrine 
and paracrine cholinergic regulation of non-neuronal cells (Wessler and 
Kirkpatrick, 2008). These autocrine and paracrine loops regulate cellular 
functions such as proliferation, differentiation, and migration (Wessler and 
Kirkpatrick, 2008). It has been determined that ACh can also alter immune 
responses. For example, release of proinflammatory molecules TNF and IL1-β 
from macrophages that express α7 nicotinic receptors can be inhibited when 
these cells are stimulated by ACh. This neuroinflammatory reflex is known as the 
cholinergic anti-inflammatory pathway (CAP) (Wessler and Kirkpatrick, 2008). 
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Inflammation occurs in the body in response to infection or injury. 
Although inflammation can lead to some unwanted secondary effects, such as 
pain, it serves to return the body to homeostasis by promoting healing within 
injured tissues and eliminating pathogens (Pavlov et al., 2003). The CAP is a 
recently identified connection between the central nervous system and the 
immune system that suppresses inflammation. In this response, pro-inflammatory 
cytokines, substances from necrotic tissues, and pathogen-associated molecular 
patterns, which are substances unique to microbes, activate afferent fibers of the 
vagus nerve (Reardon, 2016). This vagal sensory information is directed to the 
nucleus tractus solitaries in the brainstem. Some neurons in the nucleus tractus 
solitarius synapse with neurons in the rostral ventrolateral medulla. Neurons in 
the roastrol ventrolateral medulla project to the locus coeruleus, which then 
projects to sympathetic preganglionic neurons in the spinal cord (Pavlov et al., 
2003). Efferent vagal nerve fibers are also stimulated, which stimulate 
postganglionic sympathetic fibers in the celiac ganglion. These activated neurons 
release norepinephrine (NE) into the spleen, and likely into other organs as well. 
A particular group of CD4+ T-cells have β-adrenergic receptors that bind NE, 
which, upon NE binding, express the ChAT enzyme and release ACh (Reardon, 
2016). Immune cells that produce cytokines express nicotinic acetylcholine 
receptors (nAChR); ACh binds to the α7 subunit of these nAChR. As a result of 
this binding, decreased NF-κB activation, pro-inflammatory cytokine and innate 
immunity activity occurs (Tracey, 2009).  
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 The α7nAChR has been found to be expressed on macrophages, which 
are the primary immune cells that initiate inflammatory responses. TNF produced 
by LPS-activated macrophages can be dose-dependently decreased by ACh 
(Pavlov et al., 2003). Gene knockout mice for the α7nAChR gene have been 
found to be more sensitive to stimuli that induce inflammation. During 
endotoxemia a considerable increase in IL-1, IL-6, and TNF was found in the 
serum of the mice deficient in the α7nAChR versus the wild type mice. Although 
vagus nerve stimulation reduces pro-inflammatory cytokines in wild type mice 
with endotoxemia, mice deficient in the α7nAChR are unable to produce this 
same response.  Experiments have also been performed on rats to demonstrate 
the role of the CAP in localized peripheral inflammation. In a rat with paw edema, 
electrical stimulation of the distal vagus nerve reduced local inflammation. 
Additionally, when the paw was treated with ACh, muscarine, or nicotine (all of 
which are agonists that bind to and activate ACh receptors) prior to electrical 
stimulation the local inflammation of the paw was inhibited. These experiments 
demonstrate that vagal nerve stimulation or stimulation of α7nAChR 
downregulates inflammation, which provides supporting evidence of CAP 
function (Pavlov et al., 2003).  
 Research also indicates that stimulation of nAChR promotes pathogenesis 
in some infections. In a mouse model of Staphylococcus pneumoniae infection, 
inflammation and bacterial load in the lungs was significantly increased in mice 
treated with nicotine (Giebelen et al., 2009). In another study, the bacterial load 
and mortality in mice infected with Francisella tularensis was increased in groups 
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treated with either ACh or an acetylcholinesterase inhibitor, neostigmine 
(Pohanka et al., 2012). This data suggests that ACh can enhance pathogenesis 
during infection, perhaps by reducing the host inflammatory response to infection 
and, thereby, allowing the pathogen to evade host immune responses. 
Therefore, we hypothesized that genital tract infection with C. muridarum would 
increase the number of ChAT-expressing cells in the genital tract. If this 
hypothesis is correct, we would also predict that this chlamydia-induced 
production of ACh would reduce local inflammation and help the bacteria evade 
the host immune response. 
MATERIALS AND METHODS 
Animal Infections 
All protocols were approved by the University Committees on Animal 
Care, Biosafety, and Hazardous Materials and followed by the applicable state 
and federal guidelines. ChAT (BAC) eGFP female mice from Jackson Laboratory 
(strain B.6Cg-Tg (RP23-268L19-EGFP) 2Mik/J; #007902) were injected 
subcutaneously with 2.5mg/100µL medroxyprogesterone acetate suspension 
from Greenstone Pharmaceuticals 7 days before vaginal infection with C. 
muridarum. Vaginal swabs were taken for titers. The mice were then sacrificed 
by cervical dislocation on the appropriate day post infection. Immediately upon 
being sacrificed, the appropriate tissue was removed and fixed in formalin (10% 
formaldehye). Two to 3 days later the tissue was moved to 70% ethanol (EtOH). 
Tissue was then embedded in paraffin. 
Cutting and mounting embedded samples 
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Tissue samples embedded in paraffin were kept in the freezer or on ice 
until immediately before they were cut. Imbedded tissues in blocks were cut into 
5 µm sections using a microtome. Several sections were cut at once to form a 
ribbon of tissue sections, which was transferred to a piece of cardboard. A razor 
blade was then used to cut the strip into smaller, three to four section, strips. 
These smaller strips were then transferred to a 43°C water bath. Sections were 
then mounted onto glass microscope slides by lifting tissue sections out of the 
water bath with a microscope slide. These slides were then set upright in a tray 
to dry at room temperature for at least one day.  
De-paraffinization and Tissue Rehydration 
Slide-mounted sections were placed in an oven at 60°C for 1-3 hours to 
melt the paraffin. After removing the slides and letting them cool to room 
temperature, they were placed in glass boats and rehydrated in a series of baths. 
Slides were first incubated in xylene baths twice for five minutes each.  Slides 
were then placed in 100% EtOH baths twice for two minutes each, then 95% 
EtOH baths twice for two minutes each. Then slides were placed in 75% EtOH 
baths for 2 minutes followed by a 50% EtOH bath for an additional 2 minutes. 
Slides were then placed in a distilled water bath twice for 5 minutes each. Finally 
slides were placed in 0.1M phosphate buffered saline (PBS) for 5 minutes. 
Antigen retrieval proceeded immediately.  
Antigen Retrieval 
Rehydrated slides were spaced evenly in a tissue tech slide holder and 
placed in its container. The container was then filled with Antigen Retrieval 
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Solution (300mL dH2O + 0.882g sodium citrate, pH: 7). This was placed inside of 
a microwave for 3.5 minutes at full power and then for 6 minutes set at defrost. 
The container was removed from the microwave and allowed to cool to room 
temperature. The slides were then washed in distilled water 3 times for 5 minutes 
each. The Immunostaining Day 1 protocol started immediately or the slides were 
placed in IHC PBS overnight. 
Immunostaining Day 1 
 If completed the same day as the antigen retrieval protocol was 
completed, slides were rinsed in IHC PBS (29.6g Na2HPO4 + 8.6g KH2PO4 + 
14.4g NaCl + dH2O to make total volume 2L, pH 7.3) 4 times for 5 minutes each. 
If the slides were left overnight in IHC PBS, slides were rinsed only 2 times for 5 
minutes each. Slides were then rinsed with 0.5% bovine serum albumin (BSA) 
solution made in IHC PBS. Slides were then rinsed with a 1% hydrogen peroxide 
solution made in IHC PBS for 15 minutes. Then slides were rinsed with IHC PBS 
4 times for 5 minutes each, followed by a 10 minute rinse in 0.5% BSA solution. 
The slides were then removed from the tissue tech holder and then dried using a 
kimwipe. A PAP pen was then used to draw a water barrier block around each 
tissue section. The barrier was left to dry for up to a minute. Slides were then 
placed into a humidity box and tissue sections were covered with a blocking 
buffer made with 150 µl of goat serum (Vector Laboratories Catalog S-1000) and 
10 mL of 1% BSA solution. The slides were left covered in the blocking buffer in 
the humidity box for 2 hours at room temperature. The blocking buffer was then 
poured off of the slides and replaced with the primary antibody solution of 1:1000 
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dilution made of 3 µl of antibody (Anti-GFP antibody-ChIP Grade, Abcam ab290) 
and 3 ml of blocking buffer or 25 µl of Rabbit IgG (Santa Cruz sc-2027) and 2 ml 
of blocking buffer for control slides. The slides with the primary antibody covering 
the tissue sections were incubated overnight in a humidity box at room 
temperature.  
Immunostaining Day 2 
As each slide was removed from the humidity box it was rinsed with IHC 
PBS. Then the slides were placed in the tissue tech holder and rinsed with IHC 
PBS 4 times for 5 minutes each. Slides were then rinsed with 0.5% BSA solution 
for 10 minutes. The slides were placed back in the humidity box and covered with 
biotinylated secondary antibody solution. The biotinylated secondary antibody 
solution was made using 10 mL of the blocking buffer used during 
Immunostaining Day 1 and 1 drop of biotinylated secondary antibody from the 
vectastain elite ABC kit (Vector Laboratory #PK-6101). The slides were left for 2 
hours at room temperature in the humidity box. The secondary antibody solution 
was then poured off and slides were rinsed with IHC PBS as they were removed 
from the humidity box after the incubation. The slides were rinsed in IHC PBS 4 
times for 4 minutes each, then rinsed with 0.5% BSA for 10 minutes. The slides 
were then placed back in the humidity box and the tissue was covered with the 
ABC reagent. The ABC reagent was made at least 30 minutes before use and 
was made using 1 drop of solution A and 1 drop of solution B from the vectastain 
elite ABC kit and 2.5 mL of 1.0% BSA solution. The slides were left in the 
humidity box for 1.5 hours. The ABC reagent was then poured off of the tissue; 
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each slide was rinsed with tris buffered saline (TBS) (6.35g Tris-HCl + 1.18g Tris 
Base + 8.77g NaCl + 1L dH2O, pH 7.5) solution as it was removed from the 
humidity box. The slides were rinsed with TBS 4 times for 5 minutes each. During 
the last rinse the VIP substrate was prepared; it was made using 1.67 mL of IHC 
PBS and 1 drop of solutions 1, 2, and 3 and hydrogen peroxide from Vector VIP 
Peroxidase Kit (Vector Laboratories #SK-4100). The slides were placed onto a 
white background. The tissue sections were covered with the VIP solution for 2 
minutes to allow for color development. 
 After color development, each slide was rinsed with distilled water before 
placing them back into the tissue tech holder. The slides were rinsed twice for 2 
minutes each with distilled water to stop color development. The slides were then 
again placed on the white background. The tissue sections were covered with 
methyl green for 1 minute. The slides were then rinsed thoroughly with distilled 
water. The slides were then placed into glass boats to undergo the dehydration 
process, which is the reverse of the hydration process used during the De-
paraffinization and tissue re-hydration step, starting with a 50% EtOH wash for 2 
minutes and ending with two 5 minute xylene washes. The slides were then 
wiped dry with a kimwipe, avoiding the tissue sections. Coverslips were then 
attached using cytoseal. The slides were allowed to air dry in a hood overnight.  
Quantification 
After the slides were allowed to dry for at least one night, the tissue 
sections were examined underneath a microscope at 630x magnification using 
an oil immersion lens. Twelve fields were examined for each tissue section. The 
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fields were taken starting at the top left corner of the tissue, moving right across 
the tissue, then down at least one field, then moving back left across the tissue. 
This zig-zag like technique was used across the entire tissue, randomly selecting 
non-overlapping fields from all areas of the tissue section. A picture was taken of 
each field under 630x oil immersion lens. The picture was then examined to 
determine the number of positively stained cells. Dark cells with somewhat 
defined edges that were also visible when directly looking through the 
microscope were regarded as positively stained cells. The data was then 
analyzed to determine the average number of positive cells per field in each 
tissue section, microscope slide, mouse, infected mice samples, and mock mice 
samples. Statistical significance was determined for the average number of 
positively stained cells in mice infected with C. muridarum versus the non-
infected mice using a two-tailed t test; p<0.05 was used for significance. 
RESULTS 
Previous preliminary work in the Schoborg lab determined that the number 
of ChAT expressing cells increased in Chlamydia-infected cervical tissue 
compared to mock-infected (uninfected) control on days 3-21 post infection 
(Figures 2, 3).  This preliminary data lead to further experiments, first confirming 
significance in cervical tissue on day 9 post infection (Figure 4), then performing 
staining experiments on both uterine horn and ovarian tissue on days 3-21 post 
infection, labeled Chat 1 experiments (Figures 5, 6, 8, 9). Repeat experiments 
were also performed on the day 9 post infection uterine horn, labeled Chat 2 
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experiments (Figure 7) and ovarian tissue (Figure 10) to provide more data to 
support or dispute the preliminary findings.  
 
Figure 2. C. muridarum Infection Increases The Number of ChAT-
expressing Cells in Cervical Tissue Days 3-21 Post Infection. Cervical tissue 
was immunostained for ChAT expression using the IHC technique. ChAT positive 
cells were counted in random fields at magnification 630x under oil immersion. 
The pictures are representative of stained sections that were counted for the 
indicated day post infection. Arrows indicate the presence of positive staining for 
the expression of ChAT. The day post infection that the mock tissue was 
harvested is shown above each column of photographs. Mock indicates sections 
from a mock-infected mouse; Cm infected indicates sections from a C. 
muridarum infected mouse. 
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Figure 3. C. muridarum Infection Increases the Number of ChAT-expressing 
cells in Cervical Tissue Days 3-21 Post Infection. The cervical sections 
stained for the experiment shown in Figure 2 were quantified and the average 
number of cells expressing ChAT per 630x microscope field was calculated for 
random fields, as described in the Methods section. The average number of 
ChAT positive cells per field in cervical tissue is shown by the blue bars, in either 
a mock-infected mouse (mock) and C. muridarum infected mouse (infected). The 
time post infection that the tissue was harvested is shown above each graph. 
Mock and infected ChAT positive cell counts were compared using a two-tailed t 
test; p<0.05 was considered significantly different. P values obtained for each 
comparison are shown in each graph. A statistically significant difference was 
found in the number of cells expressing ChAT on days 3, 9, 15 and 21 post 
infection with C. muridarum versus those that were not infected.  
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Figure 4. C. muridarum Infection Increases Expression of ChAT in Cervical 
Tissue on Day 9 Post Infection. The average number of cells expressing ChAT 
per 630x microscope field was calculated using day 9 post infection cervical 
tissue sections from 3 mice infected with C. murdarum as well as 3 non-infected 
mice (mock) as a control. The asterisk signifies a statistically significant increase 
determined using a two-tailed t test; p <0.05 was used for significance. The p 
value for the indicated comparison is shown on the graph. These data were 
obtained from the ChAT 2 experimental repeat. 
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Figure 5. C. muridarum Infection Increases the Number of Chat-expressing 
Cells in Uterine Horn Tissue Day 9 Post Infection. Uterine horn tissue was 
immunostained for ChAT expression using the IHC technique. ChAT positive 
cells were counted in random fields at magnification 630x under oil immersion. 
The pictures are representative of stained sections that were counted for the 
indicated day post infection. Arrows indicate the presence of positive staining for 
the expression of ChAT. The day post infection that the tissue was harvested is 
shown above each column of photographs. Mock indicates sections from a 
mock-infected mouse; Cm infected indicates sections from a C. muridarum 
infected mouse.  
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Figure 6. C. muridarum Infection Increases the Number of ChAT-expressing 
cells in Uterine Horn Tissue on Day 9 Post Infection. The uterine horn 
sections stained for the experiment shown in Figure 5 were quantified and the 
average number of expressing ChAT per 630x microscope field was calculated 
as described in the Methods section. The average number of ChAT positive cells 
per field in uterine horn tissue is shown by the blue bars, in either a mock-
infected mouse (mock) and C. muridarum infected mouse (infected). The time 
post infection that the tissue was harvested is shown above each graph. Mock 
and infected ChAT positive cells counts were compared using a two-tailed t test; 
p<0.05 was considered siginifcantly different. P values obtained for each 
comparison are shown in each graph. A statistically significant difference was 
found in the number of cells expressing ChAT on day 9 post infection with C. 
muridarum versus those that were not infected.  
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FIGURE 7. C. muridarum Infection Increases Expression of ChAT in  
Uterine Horn Tissue Day 9 Post Infection. The average number of cells 
expressing ChAT per 630x microscope field was calculated using day 9 post 
infection uterine horn tissue sections from 3 mice infected with C. muridarum as 
well as 3 non-infected mice (mock) as a control. The asterisk signifies a 
statistically significant increase determined using a two-tailed t test; p<0.05 was 
used for significance. The p value for the indicated comparison is shown on the 
graph. These data were obtained from the ChAT 2 experimental repeat.   
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Figure 8. C. muridarum Infection Increases the Number of ChAT-expressing 
Cells in Ovarian Tissue Days 9-21 Post Infection. Ovarian tissue was 
immunostained for ChAT expression using the IHC technique. ChAT positive 
cells were counted in random fields at magnification 630x under oil immersion. 
The pictures are representative of stained sections that were counted for the 
indicated day post infection. Arrows indicate the presence of positive staining for 
the expression of ChAT. The day post infection that the tissue was harvested is 
shown above each column of photographs. Mock indicates sections from a 
mock-infected mouse; Cm infected indicates sections from a C. muridarum 
infected mouse. 
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Figure 9. C. muridarum Infection Increases the Number of ChAT-expressing 
cells in Ovarian Tissue Days 9-21 Post Infection. The ovarian sections stained 
for the experiment shown in Figure 8 were quantified and the average number of 
cells expressing ChAT per 630x microscope field was calculated for random 
fields, as described in the Methods section. The average number of ChAT 
positive cells per field in ovarian tissue is shown by the blue bars, in either a 
mock-infected mouse (mock) and C. muridarum infected mouse (infected). The 
time post infection that the tissue was harvested is shown above each graph. 
Mock and infected ChAT positive cell counts were compared using a two-tailed t 
test; p<0.05 was considered significantly different. P values obtained for each 
comparison are shown in each graph. A statistically significant increase was 
found in the number of cells expressing ChAT on days 9, 15, and 21 post 
infection with C. muridarum versus that that were not infected. 
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FIGURE 10. C. muridarum Infection Does Not Increase the Number of 
ChAT-Expressing Cells in Ovarian Tissue on Day 9 Post Infection. The 
average number of cells expressing ChAT per 630x microscope field was 
calculated using day 9 post infection ovarian tissue sections from 3 mice infected 
with C. muridarum as well as 3 non-infected mice (mock) as a control. It was 
determined that there was not a significant increase in the number of ChAT-
expressing cells using a two t-tailed t test; p<0.05 was used for significance. The 
p value for the indicate comparison is shown on the graph. These data were 
obtained from the ChAT 2 experimental repeat. 
 
 
 
Repeated staining experiments exhibited a significant increase in the 
number of ChAT-expressing cells on day 9 post infection in the cervix (Figure 4), 
supporting previous preliminary findings in the Schoborg lab.  As expected, ChAT 
expression was increased in Chlamydia-infected uterine horn on days 3, 9, and 
21 post infection, with a statistically significant increase in the number of ChAT-
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expressing cells on day 9 (Figure 6). Repeated staining experiments on day 9 
post infection uterine horn tissue supports the statistical significance found in the 
preliminary experiments (Figure 7). Initial experiments on ovarian tissue found 
an significant increase in ChAT-expressing cells on days 3, 9, 15, and 21 post 
infection in infected tissue versus non-infected tissue (Figure 9). Repeated 
experiments on day 9 post infection ovarian tissue did not find a significant 
increase in the expression of ChAT between infected and non-infected tissue 
(Figure 10). 
 
DISCUSSION 
Supporting our original hypothesis, data from repeated IHC staining 
experiments on day 9 post infection cervical tissue exhibits a significant increase 
in the number of cells expressing ChAT in C. muridarum infected tissue. Data 
from uterine horn tissue exhibited a significant increase of ChAT expression on 
day 9 post infection. Although initial experiments with ovarian tissue indicated a 
significant increase of ChAT expression on day 9 post infection, repeated 
experiments did not identify a significant difference. This may be the result of an 
unevenly distributed infection of the ovarian tissue, which could have caused an 
uneven distribution of ChAT-expressing cells in the ovarian tissue, as the tissue 
sections used were very small portions of the entire ovary. More experiments 
need to be carried out to determine if this disparity was due to experimental error, 
or if there is truly no significant difference in ChAT expression in ovarian tissue 
on day 9 post infection. Further experiments are also needed on all days post 
infection to substantiate or refute the general initial findings of an increase in 
	 24	
ChAT-expressing cells in Chlamydia-infected genital tract tissue versus non-
infected tissue.  
 
Figure 11. Possible Mechanisms of Enhancement of Chlamydial Infection 
 
This increase in ChAT, and therefore Ach, in the genital tract could, in fact, 
promote chlamydial infection through several different mechanisms (Figure 11). 
Direct stimulation of nAChRs by nAChR agonists, including ACh, has been 
shown to increase the growth of C. pneumoniae in human epithelial cells in vivo 
(Yamaguchi et al., 2003). Stimulation of α7nAChR by its agonists has also shown 
to decrease chemokines produced by macrophages resulting in decreased 
migration of neutrophils to the area of infection (Su et al., 2010). ACh treatment 
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also decreases expression of cellular adhesion molecules on endothelial cells, 
preventing migration of neutrophils, and therefore destruction of microbes, in 
infected tissues (Reardon et al., 2013). Human ovarian granulosa cells treated 
with acetylcholine have increased estrogen secretion (Kornya, 2001). Increased 
estrogen has been shown in animal models to increase both the severity and 
longevity of genital chlamydial infection (Rank et al., 1982). Therefore, an 
increase in production of acetylcholine in the genital tract could promote 
chlamydial infection through any or several of these mechanisms.  
As stated above, this data indicates that C. murdarium infection does 
increase the expression of ChAT in the genital tract for at least days 3-21 post 
infection. Although the mechanism is unknown, this could occur by activation of 
CAP or a CAP-independent mechanism that causes the expression of ChAT in 
genital cells. Therefore, the presence of ACh in the genital tract, or activation of 
CAP, could promote genital chlamydial infections. These findings could be 
applied to find new or improve current treatments for genital chlamydial infections 
using pre-existing acetylcholinesterase inhibitors or AChR agonists or 
antagnoists to treat these infections, and, or their sequelae.  
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